查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美直接面向消费者的基因测试市场预测至 2030 年 - 区域分析 - 按测试类型、技术和配销通路
市场调查报告书
商品编码
1463715

北美直接面向消费者的基因测试市场预测至 2030 年 - 区域分析 - 按测试类型、技术和配销通路

North America Direct-to-Consumer Genetic Testing Market Forecast to 2030 - Regional Analysis - by Test Type, Technology, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 75 Pages | 订单完成后即时交付

价格

2022年北美直接面向消费者的基因检测市值为7.164亿美元，预计到2030年将达到30.4112亿美元；预计2022年至2030年CAGR为19.8%。

遗传疾病发生率不断上升推动了北美直接面向消费者的基因检测市场

遗传疾病的全球负担正在增加。根据《卫报》2022 年发表的一篇文章，全球约 5% 的人口受到镰状细胞疾病的影响，全球每年约有 30 万名婴儿出生时患有镰状细胞贫血症。世界卫生组织估计，每 1,000 人中就有 10 人受到影响。这意味着全世界有 7,000 至 8,000 万人患有其中一种疾病。 2020 年，线上人类孟德尔遗传 (OMIM) 资源列出了 6,594 种已知分子遗传缺陷的疾病，包括 4,225 个基因。根据 Orphanet 和 OMIM 资料库，这一数字持续增加，每年约有 50-60 种新的遗传疾病。美国国立卫生研究院未确诊疾病计画和网路以及国际罕见疾病研究联盟等措施进一步加快了新型遗传疾病的发现速度。

根据疾病预防控制中心的数据，每 500 名非裔美国人中就有 1 人被诊断出患有镰状细胞疾病，每 12 名非裔美国人中就有 1 人携带常染色体隐性突变。据阿兹海默症协会称，到 2023 年，近 670 万 65 岁的美国人将患有阿兹海默症相关的痴呆症。此外，到 2060 年，这一数字预计将增至 1,380 万，而目前还没有减缓或治癒这种疾病的突破。

新生儿遗传性疾病的发生率也在增加。根据世界卫生组织2022年报告，神经管缺陷、唐氏症和心臟缺陷是几种常见的严重先天性残疾。据美国疾病预防控制中心 (CDC) 称，在美国，唐氏症每年影响近 6,000 名新生儿，即每 700 名婴儿中就有一名患有唐氏症；在印度，每年有近 23,000 至 29,000 名儿童（即 831 名儿童中就有一名）患有唐氏症。根据2021年《家庭医学和初级保健杂誌》发表的题为“神经管缺陷：不同类型以及神经形成过程及其临床意义的简要概述”的报告，超过30万例神经管缺陷（NTD）病例每年在世界范围内都有记录。这些因素鼓励对遗传性疾病进行基因检测。

因此，全球遗传性疾病发生率的增加促进了直接面向消费者的基因检测市场的成长。

北美直接面向消费者的基因检测市场概述

北美直接面向消费者的基因检测市场分为美国、加拿大和墨西哥。由于遗传疾病的日益普及、研发支出的高额、美国食品药物管理局 (FDA) 的产品批准以及技术的进步，北美占据了重要的市场份额。大型医疗保健企业的存在以及直接面向消费者的基因检测的日益普及将继续为 2022 年至 2030 年期间该地区的市场成长提供机会。此外，政府为解决对遗传疾病日益增长的担忧而提供的支持不断增加，有利于北美直接面向消费者的基因检测市场的进步。

北美直接面向消费者的基因检测市场收入及 2030 年预测（百万美元）

北美直接面向消费者的基因检测市场区隔

北美直接面向消费者的基因测试市场分为测试类型、技术、配销通路和国家。

根据测试类型，北美直接面向消费者的基因测试市场分为血统测试、预测测试、营养基因组学测试、带因者测试等。 2022 年，血统测验细分市场占据最大份额。

从技术上来看，北美直接面向消费者的基因检测市场分为全基因组定序、单核苷酸多态性晶片、标靶分析等。 2022年，单核苷酸多态性晶片领域占据最大份额。

根据配销通路，北美直接面向消费者的基因检测市场分为线上和线下。 2022 年，线上细分市场占据了更大的份额。

根据国家/地区，北美直接面向消费者的基因检测市场分为美国、加拿大和墨西哥。 2022 年，美国在北美直接面向消费者的基因检测市场占据主导地位。

Ancestry Genomics Inc、Color Health Inc、Helix Inc、Myriad Genetics, Inc.、Living DNA Ltd、23andMe Inc、Genetic Technologies Ltd、Gene by Gene Ltd 和 Full Genomes Corp Inc 是在北美直接运营的一些领先公司-对消费者的基因检测市场。

目录

表中的内容

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美直接面向消费者的基因检测市场格局

  • 概述
  • PEST分析

第 5 章：北美直接面向消费者的基因检测市场 - 主要产业动态

  • 市场驱动因素
    • 遗传性疾病的发生率不断上升
    • 提高对基因检测潜在益处的认识
  • 市场限制
    • 与直接面向消费者的基因检测相关的高成本和隐私问题
  • 市场机会
    • 单核苷酸多态性 (SNP) 晶片的采用日益广泛
  • 未来的趋势
    • 人们对药物基因学的兴趣日益浓厚，远距医疗的采用也不断增加
  • 影响分析

第 6 章：直接面向消费者的基因检测市场 - 北美市场分析

  • 概述
  • 北美直接面向消费者的基因检测市场收入，2022 - 2030

第 7 章：北美直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 按测试类型

  • 概述
  • 2022 年和 2030 年北美直接面向消费者的基因测试市场收入份额，按测试类型划分 (%)
  • 血统测试
  • 营养基因组学测试
  • 预测测试
  • 运营商测试
  • 其他的

第 8 章：北美直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年和 2030 年北美直接面向消费者的基因检测市场收入份额（按技术划分）（%）
  • 全基因组定序
  • 单核苷酸多态性晶片
  • 针对性分析
  • 其他的

第 9 章：北美直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 按配销通路

  • 概述
  • 2022 年和 2030 年北美直接面向消费者的基因检测市场收入份额（按配销通路划分）（%）
  • 线上平台
  • 线下平台

第 10 章：北美直接面向消费者的基因检测市场 - 收入和 2030 年预测 - 国家分析

  • 我们
  • 加拿大
  • 墨西哥

第 11 章：北美直接面向消费者的基因检测市场-产业格局

  • 概述
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 12 章：公司简介

  • Ancestry Genomics Inc
  • Color Health Inc
  • Helix Inc
  • Myriad Genetics, Inc.
  • Living DNA Ltd
  • 26andMe Inc
  • Genetic Technologies Ltd
  • Gene By Gene Ltd
  • Full Genomes Corp Inc

第 13 章：附录

Product Code: BMIRE00029622

The North America Direct-to-Consumer genetic testing market was valued at US$ 716.40 million in 2022 and is expected to reach US$ 3,041.12 million by 2030; it is estimated to grow at a CAGR of 19.8% from 2022 to 2030.

Growing Incidence of Genetic Disorders Fuels the North America Direct-to-Consumer Genetic Testing Market

The global burden of genetic diseases is increasing. According to an article published in 2022 by The Guardian, ~5% of the world's population is affected by sickle cell disease, and approximately 300,000 babies are born with sickle cell anemia worldwide every year. The World Health Organization estimates that 10 in 1,000 people are affected. This means 70 to 80 million people worldwide live with one of these diseases. In 2020, the Online Mendelian Inheritance in Man (OMIM) resource listed 6,594 diseases with known molecular genetic defects, comprising 4,225 genes. This number is continuously increasing to approximately 50-60 new genetic diseases annually, as per the Orphanet and OMIM databases. The NIH Undiagnosed Diseases Program and Network and the International Rare Diseases Research Consortium are a few initiatives further accelerating the discovery rate of novel genetic diseases.

According to the CDC, 1 in 500 African Americans are diagnosed with sickle cell disease, and the autosomal recessive mutation is carried by 1 in 12 African Americans. According to the Alzheimer's Association, by 2023, nearly 6.7 million Americans aged 65 will have Alzheimer's-related dementia. Furthermore, the number is expected to rise to 13.8 million by 2060, with no breakthrough that either slows or cures the disease.

The incidence of genetic disorders in newborns is also increasing. According to the World Health Organization 2022 report, neural tube defects, Down syndrome, and heart defects are a few common severe congenital disabilities. According to the CDC, in the US, Down syndrome affects nearly 6,000 newborn babies yearly, one in 700 babies; and in India, every year, nearly 23,000 to 29,000 children, one in 831, have Down syndrome. According to the report titled "Neural tube defects: Different types and a brief overview of the neurulation process and its clinical implications," published in the Journal of Family Medicine and Primary Care in 2021, more than 300,000 cases of Neural tube defects (NTDs) are recorded worldwide each year. These factors are encouraging the introduction of genetic testing for inherited diseases.

Therefore, the increasing incidence of genetic disorders worldwide boosts the Direct-to-Consumer genetic testing market growth.

North America Direct-to-Consumer Genetic Testing Market Overview

The North America Direct-to-Consumer genetic testing market is segmented into the US, Canada, and Mexico. North America accounts for a significant market share owing to the growing prevalence of genetic diseases, high spending on research and development, product approvals by the US Food and Drug Administration (FDA), and technological advances. The presence of large healthcare businesses and the growing usage of Direct-to-Consumer genetic testing would continue to offer opportunities for market growth in the region during the period 2022-2030. Further, rising support from governments to address growing concerns about genetic diseases favors the Direct-to-Consumer genetic testing market progress in North America.

North America Direct-to-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)

North America Direct-to-Consumer Genetic Testing Market Segmentation

The North America Direct-to-Consumer genetic testing market is segmented into test type, technology, distribution channel, and country.

Based on test type, the North America Direct-to-Consumer genetic testing market is segmented into ancestry testing, predictive testing, nutrigenomics testing, carrier testing, and others. The ancestry testing market segment held the largest share in 2022.

In terms of technology, the North America Direct-to-Consumer genetic testing market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held the largest share in 2022.

Based on distribution channel, the North America Direct-to-Consumer genetic testing market is bifurcated into online and offline. The online segment held a larger share in 2022.

Based on country, the North America Direct-to-Consumer genetic testing market is segmented the US, Canada, and Mexico. The US dominated the North America Direct-to-Consumer genetic testing market in 2022.

Ancestry Genomics Inc, Color Health Inc, Helix Inc, Myriad Genetics, Inc., Living DNA Ltd, 23andMe Inc, Genetic Technologies Ltd, Gene by Gene Ltd, and Full Genomes Corp Inc are some of the leading companies operating in the North America Direct-to-Consumer genetic testing market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Direct-to-Consumer Genetic Testing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. North America Direct-to-Consumer Genetic Testing Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Incidence of Genetic Disorders
    • 5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
  • 5.4 Future Trends
    • 5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
  • 5.5 Impact Analysis

6. Direct-to-Consumer Genetic Testing Market - North America Market Analysis

  • 6.1 Overview
  • 6.2 North America Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 - 2030

7. North America Direct-to-Consumer genetic testing market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 North America Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 Ancestry Testing
    • 7.3.1 Overview
    • 7.3.2 Ancestry Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Nutrigenomics Testing
    • 7.4.1 Overview
    • 7.4.2 Nutrigenomics Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Predictive Testing
    • 7.5.1 Overview
    • 7.5.2 Predictive Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Carrier Testing
    • 7.6.1 Overview
    • 7.6.2 Carrier Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Direct-to-Consumer genetic testing market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 North America Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Whole Genome Sequencing
    • 8.3.1 Overview
    • 8.3.2 Whole Genome Sequencing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Single Nucleotide Polymorphism Chips
    • 8.4.1 Overview
    • 8.4.2 Single Nucleotide Polymorphism Chips: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Targeted Analysis
    • 8.5.1 Overview
    • 8.5.2 Targeted Analysis: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Direct-to-Consumer genetic testing market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 North America Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Online Platform
    • 9.3.1 Overview
    • 9.3.2 Online Platform: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Offline Platform
    • 9.4.1 Overview
    • 9.4.2 Offline Platform: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 North America Direct-to-Consumer Genetic Testing Market, by Key Country- Revenue (2022) (US$ Mn)
    • 10.1.1 North America Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
      • 10.1.1.1 US: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.2 US: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 US: North America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2 US: North America Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.3 US: North America Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.3 Canada: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.4 Canada: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Canada: North America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2 Canada: North America Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Canada: North America Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.5 Mexico: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.6 Mexico: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Mexico: North America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2 Mexico: North America Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.6.3 Mexico: North America Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)

11. North America Direct-to-Consumer Genetic Testing Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Ancestry Genomics Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Color Health Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Helix Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Myriad Genetics, Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Living DNA Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 26andMe Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Genetic Technologies Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Gene By Gene Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Full Genomes Corp Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Direct-to-Consumer genetic testing market Segmentation
  • Table 2. US: North America Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Canada: North America Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Canada: North America Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada: North America Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Mexico: North America Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Mexico: North America Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Mexico: North America Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Organic Developments Done by Companies
  • Table 12. Inorganic Developments Done by Companies
  • Table 13. Glossary of Terms, North America Direct-to-Consumer Genetic Testing Market

List Of Figures

  • Figure 1. North America Direct-to-Consumer genetic testing market Segmentation, By Country
  • Figure 2. PEST Analysis
  • Figure 3. North America Direct-to-Consumer Genetic Testing Market: Key Industry Dynamics
  • Figure 4. North America Direct-to-Consumer Genetic Testing Market: Impact Analysis of Drivers and Restraints
  • Figure 5. North America Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. North America Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 7. Ancestry Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Nutrigenomics Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Predictive Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Carrier Testing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 13. Whole Genome Sequencing: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Single Nucleotide Polymorphism Chips: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Targeted Analysis: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Others: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. North America Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 18. Online Platform: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Offline Platform: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Direct-to-Consumer Genetic Testing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 21. North America Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
  • Figure 22. US: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Canada: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Mexico: North America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)